Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA warning letters plunge under Bush reign

This article was originally published in Clinica

Executive Summary

FDA enforcement activity has dropped precipitously during the Bush administration, as seen by an over 50% decline in warning letter numbers, according to a 15-month investigation by Democratic Representative Henry Waxman, of California. "Americans have relied on FDA to ensure the safety of their food and drugs for 100 years," said Mr Waxman. "But under the Bush administration, enforcement efforts have plummeted, and serious violations are ignored. The FDA cannot do its job when its enforcement arm is tied behind its back."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052118

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel